Last updated: 2026-09-05 07:38:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Stryker Corporation (SYK) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NYSE. The stock is currently priced at $303.13, with a market capitalisation of $118.14B and a P/E ratio of 31.18. Over the past 52 weeks, its price has ranged from $281.00 to $396.37. This page covers its latest market performance, valuation, price trends and company information.
$118.14B | |
$304.49 | |
$406.19 | |
$30.82 | |
$307.99 | |
1.92M | |
2.45M | |
31.18 | |
$396.37 | |
$281.00 | |
1.13% | |
-- |
Stryker Corporation (SYK) last closed at $307.99 as of 2026-09-04 23:58:00, unchanged from the previous close of $307.99.
During the latest regular trading session, SYK traded between $30.82 and $406.19, with a volume of 1.92M shares. The closing price was near the upper end and near the lower end of its 52-week range.
Over the past seven days, Stryker Corporation (SYK) moved from $322.12 to $303.13, representing a decline of 5.89% ($18.99).
The stock traded between $302.51 and $332.72 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 2.26 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 19.2%
SYK is currently trading at $303.13, placing it 19.2% of the way from its 52-week low of $281.00 to its 52-week high of $396.37. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, mechanical thrombectomy systems, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 56000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Stryker Corporation (SYK) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.